Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Type 2 Diabetes”

128 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 128 results

Post-approval studies (Phase 4)Study completedNCT03030300
What this trial is testing

Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy

Who this might be right for
Type2 Diabetes
Qianfoshan Hospital 170
Not applicableStudy completedNCT01154244
What this trial is testing

Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 1,439
Not applicableStudy completedNCT01895387
What this trial is testing

Dietary Effects on Circulating Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity and Enzyme Activity in Peripheral Blood Mononuclear Cells (PBMCs) in Patients With Prediabetes or Newly Diagnosed Type 2 Diabetes

Who this might be right for
Impaired Fasting GlucoseNewly Diagnosed Type 2 Diabetes
Yonsei University 100
Post-approval studies (Phase 4)UnknownNCT01095822
What this trial is testing

Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics

Who this might be right for
Diabetes Mellitus
HeartDrug Research LLC 50
Not applicableStudy completedNCT01521624
What this trial is testing

Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes Mellitus
Tehran University of Medical Sciences 108
Not applicableUnknownNCT03180281
What this trial is testing

Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell

Who this might be right for
Type 2 Diabetes Mellitus
First Affiliated Hospital Xi'an Jiaotong University 135
Not applicableStudy completedNCT01593371
What this trial is testing

Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes Mellitus
Tehran University of Medical Sciences 98
Not applicableStudy completedNCT01409330
What this trial is testing

German Diabetes-Diet-Intervention and Energy Restriction-Trial (DDIET)

Who this might be right for
Type 2 Diabetes
German Diabetes Center 40
Post-approval studies (Phase 4)UnknownNCT06127433
What this trial is testing

The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes

Who this might be right for
Insulin Pump，Continuous Glucose Monitoring Technology
Sun Yat-sen University 210
Not applicableUnknownNCT05228561
What this trial is testing

The Effect of Mobile Application Supported Diabetes Education On Type 2 Diabetes Self-Management And Blood Sugar Level

Who this might be right for
Diabetes Mellitus, Type 2EducationMobile Applications+1 more
Ege University 140
Not applicableUnknownNCT02143440
What this trial is testing

The Initial Assessment of Daily Insulin Dose in Newly Diagnosed Type 2 Diabetes

Who this might be right for
Type 2 Diabetes.
RenJi Hospital 65
Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Not applicableStudy completedNCT05284344
What this trial is testing

The Impact of Glucotoxicity on Gastric Emptying in Chinese Patients With Newly Diagnosed Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Adelaide 78
Not applicableStudy completedNCT00232583
What this trial is testing

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
University of Texas Southwestern Medical Center 58
Testing effectiveness (Phase 2)UnknownNCT01101503
What this trial is testing

The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes

Who this might be right for
Endothelial Dysfunction
Xiang Guang-da 1,000
Large-scale testing (Phase 3)Study completedNCT00551954
What this trial is testing

Effects of Acarbose on Endothelial Function After a Mixed Meal in Newly Diagnosed Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Technische Universität Dresden
Not applicableUnknownNCT01898572
What this trial is testing

Carotid Atherosclerosis In Newly Diagnosed Type 2 Individuals

Who this might be right for
Type II Diabetes Mellitus Without Mention of Complication
Hospital Clinic of Barcelona 200
Not applicableStudy completedNCT04665570
What this trial is testing

Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D)

Who this might be right for
Type 2 Diabetes Mellitus
Bayer 2,000
Post-approval studies (Phase 4)UnknownNCT03972982
What this trial is testing

Effects of Structured Simplified Short-term Intensive Insulin Therapy on Long-term Glycemic Remission

Who this might be right for
Newly Diagnosed Type 2 DiabetesSimplified Short-term Intensive Insulin TherapyGlycemic Remission
Sun Yat-sen University 330
Post-approval studies (Phase 4)UnknownNCT00254085
What this trial is testing

Substitution of First Phase Insulin Response in Patient With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes
University Hospital, Gentofte, Copenhagen 20
Load More Results